Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?

Nature Clinical Practice Nephrology volume 2, pages 76–77 (2006)Cite this article

boxed-textWanner C et al. (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238–248

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Weiner DE et al. (2004) Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 44: 198–206

    Article  Google Scholar 

  2. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383–1389

  3. Colhoun HM et al. (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364: 685–696

    Article  CAS  Google Scholar 

  4. Seliger SL et al. (2002) HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61: 297–304

    Article  CAS  Google Scholar 

  5. United States Renal Data System (online 1 September 2005) [http://www.usrds.org] (accessed 1 September 2005)

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Prince of Wales Hospital, Hong Kong, and a research fellow at the University of Utah, Salt Lake City, UT, USA

    Bonnie C-H Kwan

  2. Veterans Affairs Salt Lake City Healthcare System (VASLC-HCS) and Assistant Professor of Medicine in the Division of Nephrology & Hypertension at the University of Utah,

    Srinivasan Beddhu

  3. Head of the Division of Genetic Epidemiology at Innsbruck Medical University, Austria

    Florian Kronenberg

  4. VASLC-HCS, Dialysis Research Foundation Professor of Medicine and Executive Director of the Dialysis Program at the University of Utah,

    Alfred K Cheung

Authors
  1. Bonnie C-H Kwan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Srinivasan Beddhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Florian Kronenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alfred K Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfred K Cheung.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kwan, BH., Beddhu, S., Kronenberg, F. et al. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?. Nat Rev Nephrol 2, 76–77 (2006). https://doi.org/10.1038/ncpneph0101

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0101

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing